Skip to main content
. Author manuscript; available in PMC: 2022 Nov 30.
Published in final edited form as: Curr Protoc Pharmacol. 2020 Jun;89(1):e76. doi: 10.1002/cpph.76

Figure 1.

Figure 1.

Schematics of autologous reconstitution of human solid tumors. PDX is patient derived xenoplants, BMC bone marrow cells, and TME tumor microenvironment. The recipient mice (e.g. NOG, NSG, NSG-HLA-A2, NSG-IL-6, etc.) can vary depending on the aims of the experiment. Both engraftment of the PDX tumor and BMC should be performed with NOG/NSG mice.